scholarly article | Q13442814 |
P356 | DOI | 10.3109/00016348109158127 |
P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.3109%2F00016348109158127 |
https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.3109/00016348109158127 | ||
P698 | PubMed publication ID | 7270093 |
P50 | author | Margareta Eriksson | Q77928448 |
Rolf Zetterström | Q6252300 | ||
P2093 | author name string | G. Larsson | |
P2860 | cites work | Effects of antenatal exposure to anorectic drugs | Q67707118 |
Effect of heroin withdrawal on respiratory rate and acid-base status in the newborn | Q70372515 | ||
Amphetamine ingestion with biliary atresia | Q70526064 | ||
Homologies for congenital heart diseases: murine models, influenced by dextroamphetamine | Q72322935 | ||
Brain malformations related to prenatal exposure to ethanol | Q34249904 | ||
Impaired growth in hyperkinetic children receiving pemoline | Q34698048 | ||
Ill-health and child abuse | Q39338690 | ||
Drug dependence and pregnancy: a review of the problems and their management | Q40025828 | ||
Perinatal addiction: Outcome and management | Q40661354 | ||
Dexamphetamine: a possible environmental trigger in cardiovascular malformations | Q42231075 | ||
Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases | Q43949459 | ||
Narcotic Addiction, Pregnancy, and the Newborn | Q44676210 | ||
Amphetamine addiction and pregnancy. Psycho-social and medical aspects | Q44862715 | ||
The effect of availability and utilization of prenatal care and hospital services on infant mortality rates. Summary of the findings of the Louisiana Infant Mortality Study. Part II | Q46205876 | ||
Effect of maternal heroin addiction on 67 liveborn neonates. Withdrawal symptoms, small body size, and small head circumference were frequent findings | Q46390340 | ||
Delivery patterns and reproductive efficiency among groups of differing socioeconomic status and ethnic origins | Q47781928 | ||
Neonatal seizures associated with narcotic withdrawal | Q48259473 | ||
The influence of amphetamine addiction on pregnancy and the newborn infant | Q52264297 | ||
The Case History of an Infant Born to an Amphetamine- Addicted Mother | Q52268806 | ||
Heroin addiction during pregnancy. | Q52268912 | ||
Narcotic addiction in pregnancy | Q52269035 | ||
NARCOTIC AND METHAMPHETAMINE USE DURING PREGNANCY. EFFECT ON NEWBORN INFANTS. | Q52284215 | ||
Drug patterns among drug-addicted mothers: incidence, variance in use, and effects on children. | Q52304702 | ||
Therapy of heavy drinking during pregnancy | Q52966155 | ||
Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. | Q54044687 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neonate | Q576104 |
maternal health | Q6786626 | ||
P304 | page(s) | 253-259 | |
P577 | publication date | 1981-01-01 | |
P1433 | published in | Acta Obstetricia et Gynecologica Scandinavica | Q4676737 |
P1476 | title | Amphetamine addiction and pregnancy. II. Pregnancy, delivery and the neonatal period. Socio-medical aspects | |
P478 | volume | 60 |
Q33608607 | 'Crystal' and pregnancy--methamphetamine-associated maternal deaths |
Q34754214 | Abnormalities in parentally rated executive function in methamphetamine/polysubstance exposed children |
Q43506328 | Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15 years |
Q38015058 | Amphetamines, the pregnant woman and her children: a review |
Q34532827 | Children exposed to methamphetamine use and manufacture |
Q42277683 | Consumption coagulopathy after amphetamine abuse in pregnancy |
Q33439633 | Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analyt |
Q37733260 | Drug use in pregnancy: obstetric perspectives. |
Q37649900 | Effects of methamphetamine abuse beyond individual users |
Q38174009 | Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies. |
Q35799895 | Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women |
Q46881462 | Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study |
Q35220283 | Methamphetamines and pregnancy outcomes |
Q30483016 | Neonatal amphetamine exposure and hippocampus-mediated behaviors |
Q41926571 | Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. |
Q30481358 | Neuroimaging of children following prenatal drug exposure |
Q40399866 | Perinatal and neonatal issues of substance abuse. |
Q44370749 | Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates |
Q35658188 | Perinatal effects of cocaine and amphetamine use during pregnancy |
Q50146408 | Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation |
Q92649154 | Prenatal Exposure to Methamphetamine: Up-Regulation of Brain Receptor Genes |
Q41740836 | Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy |
Q37719523 | Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years |
Q37029535 | Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes |
Q64135867 | Recognizing illicit drug use by pregnant women: reports from Oregon birth attendants |
Q42726326 | Stillbirth due to intravenous amphetamine |
Q52274510 | Support to drug-addicted parents: a help to the children? |
Q41479383 | The incidence, classification, etiology, and embryology of oral clefts |
Q33600834 | Treatment strategies for drug-exposed neonates. |
Search more.